Author name: admin

Uncategorized

New Releases from NCBI BookshelfIntervening to eliminate the centre-effect variation in home dialysis use: a synopsis of Inter-CEPt, an exploratory sequential mixed-methods study.​Intervening to eliminate the centre-effect variation in home dialysis use: a synopsis of Inter-CEPt, an exploratory sequential mixed-methods study.

There is a substantial variation in the use of home dialysis between kidney services, which disproportionally affects people from ethnic

Uncategorized

New Releases from NCBI BookshelfClinical utility of biomarkers for outcomes prediction in adults with suspected sepsis presenting to the emergency department: a synthesis of current evidence [Internet].​Clinical utility of biomarkers for outcomes prediction in adults with suspected sepsis presenting to the emergency department: a synthesis of current evidence [Internet].

Sepsis is characterised as life-threatening organ dysfunction due to a dysregulated host response to infection. It carries high mortality and

Uncategorized

New Releases from NCBI BookshelfMR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study.​MR-Pro-adrenomedullin (MR-proADM) and Host Immune Response Biomarkers Evaluation of procalcitonin-guided antibiotic duration in Children with Infection for Stratification of Effectiveness: the PRECISE Study.

The host-response to bacterial infection is highly heterogeneous; there is therefore a need for stratified treatment strategies instead of the

Uncategorized

New Releases from NCBI BookshelfComparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer—The PRO-TECT Trial [Internet].​Comparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer—The PRO-TECT Trial [Internet].

Patients commonly have symptoms during cancer treatment that can go undetected. Symptom monitoring with electronic patient-reported outcome (ePRO) surveys may

Scroll to Top